Incidence and risk factors of venous thromboembolism in kidney transplantation patients: a prospective cohort study

被引:0
作者
Zhao, Shangping [1 ]
Chen, Hong [2 ]
Shi, Xiaoying [1 ]
Tan, Qiling [1 ]
Gu, Bo [1 ]
机构
[1] Sichuan Univ, West China Hosp, Ward Nephrol & Urol, West China Sch Nursing, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Sch Nursing, Chengdu, Sichuan, Peoples R China
关键词
Venous thromboembolism; Kidney transplantation; Incidence; Deep venous thrombosis; Risk factor; DEEP-VEIN THROMBOSIS; RENAL-TRANSPLANTATION; EVENTS; RECIPIENTS;
D O I
10.1007/s11239-023-02911-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the incidence and explore the risk factors of venous thromboembolism (VTE) within 6 months after kidney transplantation. Total of 331 kidney transplant recipients were assessed by venous ultrasonography for VTE at 14 days, 1 month, 3 months, and 6 months post-transplantation. Cox forward regression were used to identify the independent risk factors of VTE. This study registration number is ChiCTR1900020567 and the date of registration was 2019/01/08. The cumulative incidence of VTE was 2.72% (9/331) within 6 months after transplant. 77.8% (7/9) of VTEs occurred in the first 3 months post-transplantation. 88.9% (1/9) of VTEs were asymptomatic, 66.7% (6/9) of VTEs were mural thromboses and in the right lower extremity. Central vena catheterization (HR = 6.94) and severe pulmonary disease (including pneumonia) (HR = 57.35) were the risk factors for VTE in kidney transplantation recipients. KT patients are the high risk population of VTE. Future interventions should be strengthen for KT patients to receive a minimum of 3-month of precautionary measures for VTE, including infection prevention, and strengthening thromboprophylaxis on the CVC or transplanted side of lower extremity.
引用
收藏
页码:278 / 284
页数:7
相关论文
共 34 条
  • [1] Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States
    Abbott, KC
    Cruess, DF
    Agodoa, LYC
    Sawyers, ES
    Tveit, DP
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (01) : 120 - 130
  • [2] Abualhassan N, 2015, SAUDI J KIDNEY DIS T, V26, P1
  • [3] The incidence and risk factors for deep vein thrombosis after kidney transplantation in Korea: single-center experience
    Ahn, Sanghyun
    Kim, Mi-Hyeong
    Jun, Kang-Woong
    Hwang, Jeong-Kye
    Park, Soon-Chul
    Moon, In-Sung
    Kim, Ji-Iil
    [J]. CLINICAL TRANSPLANTATION, 2015, 29 (12) : 1181 - 1186
  • [4] Aksu K, 2012, CURR PHARM DESIGN, V18, P1478
  • [5] COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
    Al-Samkari, Hanny
    Leaf, Rebecca S. Karp
    Dzik, Walter H.
    Carlson, Jonathan C. T.
    Fogerty, Annemarie E.
    Waheed, Anem
    Goodarzi, Katayoon
    Bendapudi, Pavan K.
    Bornikova, Larissa
    Gupta, Shruti
    Leaf, David E.
    Kuter, David J.
    Rosovsky, Rachel P.
    [J]. BLOOD, 2020, 136 (04) : 489 - 500
  • [6] Venous thromboembolism in Asia - an unrecognised and under-treated problem?
    Angchaisuksiri, Pantep
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 106 (04) : 585 - 590
  • [7] Virchow and his triad: a question of attribution
    Bagot, Catherine N.
    Arya, Roopen
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (02) : 180 - 190
  • [8] Donor Graft Cytomegalovirus Serostatus and the Risk of Arterial and Venous Thrombotic Events in Seronegative Recipients After Non-Thoracic Solid Organ Transplantation
    Belga, Sara
    MacDonald, Clayton
    Chiang, Diana
    Kabbani, Dima
    Shojai, Soroush
    Abraldes, Juan G.
    Cervera, Carlos
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 72 (05) : 845 - 852
  • [9] Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation
    Camporese, G.
    Bernardi, D.
    Bernardi, E.
    Avruscio, G. P.
    Marchini, F.
    Bonfante, L.
    Furian, L.
    Neri, F.
    Villalta, S.
    Fabris, F.
    Simioni, P.
    Sartori, M. T.
    [J]. VASCULAR PHARMACOLOGY, 2020, 130
  • [10] Thrombosis risk assessment as a guide to quality patient care
    Caprini, JA
    [J]. DM DISEASE-A-MONTH, 2005, 51 (2-3): : 70 - 78